Trgovina Synlogic - SYBX CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.05 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Synlogic Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Predhodno. Zapri* | 0.52 |
Odpri* | 0.53 |
Enoletna sprememba* | -50.93% |
Dnevni razpon* | 0.51 - 0.54 |
Razpon 52 wk | 0.45-1.35 |
Povprečni obseg (10 dni) | 151.76K |
Povprečni obseg (3 meseci) | 6.40M |
Tržna kapitalizacija | 38.20M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 68.21M |
Prihodki | 1.11M |
EPS | -0.93 |
Dividenda (donosnost v %) | N/A |
Beta | 1.03 |
Datum naslednjega zaslužka | Aug 9, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
May 26, 2023 | 0.53 | 0.00 | 0.00% | 0.53 | 0.54 | 0.51 |
May 25, 2023 | 0.52 | 0.00 | 0.00% | 0.52 | 0.55 | 0.51 |
May 24, 2023 | 0.55 | 0.02 | 3.77% | 0.53 | 0.55 | 0.52 |
May 23, 2023 | 0.54 | 0.00 | 0.00% | 0.54 | 0.55 | 0.54 |
May 22, 2023 | 0.53 | 0.00 | 0.00% | 0.53 | 0.55 | 0.53 |
May 19, 2023 | 0.54 | -0.01 | -1.82% | 0.55 | 0.56 | 0.50 |
May 18, 2023 | 0.55 | 0.02 | 3.77% | 0.53 | 0.55 | 0.53 |
May 17, 2023 | 0.54 | 0.03 | 5.88% | 0.51 | 0.54 | 0.51 |
May 16, 2023 | 0.51 | -0.02 | -3.77% | 0.53 | 0.53 | 0.51 |
May 15, 2023 | 0.53 | -0.03 | -5.36% | 0.56 | 0.56 | 0.52 |
May 12, 2023 | 0.53 | -0.01 | -1.85% | 0.54 | 0.54 | 0.52 |
May 11, 2023 | 0.53 | 0.01 | 1.92% | 0.52 | 0.55 | 0.49 |
May 10, 2023 | 0.53 | 0.03 | 6.00% | 0.50 | 0.54 | 0.49 |
May 9, 2023 | 0.49 | -0.17 | -25.76% | 0.66 | 0.66 | 0.45 |
May 8, 2023 | 0.53 | 0.00 | 0.00% | 0.53 | 0.58 | 0.51 |
May 5, 2023 | 0.52 | -0.01 | -1.89% | 0.53 | 0.53 | 0.52 |
May 4, 2023 | 0.52 | 0.00 | 0.00% | 0.52 | 0.54 | 0.51 |
May 3, 2023 | 0.52 | 0.03 | 6.12% | 0.49 | 0.56 | 0.48 |
May 2, 2023 | 0.47 | -0.05 | -9.62% | 0.52 | 0.52 | 0.47 |
May 1, 2023 | 0.50 | -0.09 | -15.25% | 0.59 | 0.62 | 0.50 |
Synlogic Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
Wednesday, June 7, 2023 | ||
Čas (UTC) (UTC) 10:59 | Država US
| Dogodek Synlogic Inc at Jefferies Healthcare Conference Synlogic Inc at Jefferies Healthcare ConferenceForecast -Previous - |
Čas (UTC) (UTC) 18:00 | Država US
| Dogodek Synlogic Inc at Jefferies Healthcare Conference Synlogic Inc at Jefferies Healthcare ConferenceForecast -Previous - |
Friday, June 9, 2023 | ||
Čas (UTC) (UTC) 13:00 | Država US
| Dogodek Synlogic Inc Annual Shareholders Meeting Synlogic Inc Annual Shareholders MeetingForecast -Previous - |
Thursday, June 15, 2023 | ||
Čas (UTC) (UTC) 12:00 | Država US
| Dogodek Synlogic Inc Annual Shareholders Meeting Synlogic Inc Annual Shareholders MeetingForecast -Previous - |
Wednesday, August 9, 2023 | ||
Čas (UTC) (UTC) 12:30 | Država US
| Dogodek Q2 2023 Synlogic Inc Earnings Release Q2 2023 Synlogic Inc Earnings ReleaseForecast -Previous - |
Wednesday, November 8, 2023 | ||
Čas (UTC) (UTC) 11:59 | Država US
| Dogodek Q3 2023 Synlogic Inc Earnings Release Q3 2023 Synlogic Inc Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 1.18 | 1.754 | 0.545 | 2.224 | 2.52 |
Prihodki | 1.18 | 1.754 | 0.545 | 2.224 | 2.52 |
Celotni odhodki iz poslovanja | 68.599 | 62.519 | 61.011 | 56.633 | 53.75 |
Celotna prodaja/splošni/upravni stroški Odhodki | 16.555 | 15.392 | 13.537 | 14.728 | 15.716 |
Raziskave in razvoj | 52.044 | 47.127 | 47.474 | 41.905 | 38.034 |
Prihodki iz poslovanja | -67.419 | -60.765 | -60.466 | -54.409 | -51.23 |
Prihodki (odhodki) od obresti, neto Neoperativni | 1.265 | 0.208 | 1.296 | 3.041 | 2.8 |
Čisti dobiček pred obdavčitvijo | -66.147 | -60.561 | -59.173 | -51.373 | -48.435 |
Čisti dobiček po davkih | -66.147 | -60.561 | -59.173 | -51.373 | -48.435 |
Čisti dobiček pred dodatnimi postavkami | -66.147 | -60.561 | -59.173 | -51.373 | -48.435 |
Čisti dobiček | -66.147 | -60.561 | -59.173 | -51.373 | -48.435 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -66.147 | -60.561 | -59.173 | -51.373 | -48.435 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -66.147 | -60.561 | -59.173 | -51.373 | -48.435 |
Popravljen čisti dobiček | -66.147 | -60.561 | -59.173 | -51.373 | -48.435 |
Popravljene ponderirane povprečne delnice | 71.7255 | 55.3297 | 35.8357 | 30.2841 | 23.8827 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.92222 | -1.09455 | -1.65123 | -1.69637 | -2.02804 |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.92222 | -1.09455 | -1.65123 | -1.69637 | -2.02804 |
Drugo, neto | 0.007 | -0.004 | -0.003 | -0.005 | -0.005 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 0.174 | 0.106 | 0.678 | 0.152 | 0.244 |
Prihodki | 0.174 | 0.106 | 0.678 | 0.152 | 0.244 |
Celotni odhodki iz poslovanja | 16.417 | 17.409 | 19.012 | 16.169 | 16.009 |
Celotna prodaja/splošni/upravni stroški Odhodki | 3.967 | 3.77 | 4.402 | 4.112 | 4.271 |
Raziskave in razvoj | 12.45 | 13.639 | 14.61 | 12.057 | 11.738 |
Prihodki iz poslovanja | -16.243 | -17.303 | -18.334 | -16.017 | -15.765 |
Prihodki (odhodki) od obresti, neto Neoperativni | 0.627 | 0.61 | 0.421 | 0.168 | 0.066 |
Drugo, neto | -0.006 | -0.003 | 0.001 | 0.007 | 0.002 |
Čisti dobiček pred obdavčitvijo | -15.622 | -16.696 | -17.912 | -15.842 | -15.697 |
Čisti dobiček po davkih | -15.622 | -16.696 | -17.912 | -15.842 | -15.697 |
Čisti dobiček pred dodatnimi postavkami | -15.622 | -16.696 | -17.912 | -15.842 | -15.697 |
Čisti dobiček | -15.622 | -16.696 | -17.912 | -15.842 | -15.697 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -15.622 | -16.696 | -17.912 | -15.842 | -15.697 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -15.622 | -16.696 | -17.912 | -15.842 | -15.697 |
Popravljen čisti dobiček | -15.622 | -16.696 | -17.912 | -15.842 | -15.697 |
Popravljene ponderirane povprečne delnice | 69.0702 | 70.7161 | 72.1081 | 72.1062 | 71.969 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.22618 | -0.2361 | -0.2484 | -0.2197 | -0.21811 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.22618 | -0.2361 | -0.2484 | -0.2197 | -0.21811 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 79.782 | 133.309 | 106.846 | 133.246 | 124.338 |
Denarna sredstva in kratkoročne naložbe | 77.629 | 128.588 | 100.444 | 119.571 | 122.729 |
Denarna sredstva in ustrezniki | 15.861 | 16.438 | 32.507 | 26.184 | 11.252 |
Kratkoročne naložbe | 61.768 | 112.15 | 67.937 | 93.387 | 111.477 |
Prepaid Expenses | 1.978 | 4.41 | 6.155 | 13.027 | 1.221 |
Total Assets | 110.865 | 174.736 | 143.84 | 188.574 | 140.34 |
Property/Plant/Equipment, Total - Net | 21.679 | 22.977 | 26.303 | 30.284 | 14.841 |
Other Long Term Assets, Total | 9.404 | 10.409 | 10.691 | 17.542 | 1.161 |
Total Current Liabilities | 12.122 | 10.08 | 8.301 | 8.863 | 8.341 |
Accounts Payable | 1.785 | 1.944 | 1.995 | 2.165 | 2.38 |
Accrued Expenses | 9.442 | 7.593 | 6.304 | 5.946 | 5.034 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.013 | 0.012 | 0.002 | 0.208 | 0.266 |
Other Current Liabilities, Total | 0.882 | 0.531 | 0.544 | 0.661 | |
Total Liabilities | 28.255 | 27.47 | 28.705 | 31.669 | 16.242 |
Total Long Term Debt | 0.004 | 0.018 | 0 | 0.002 | 0.21 |
Capital Lease Obligations | 0.004 | 0.018 | 0.002 | 0.21 | |
Other Liabilities, Total | 16.129 | 17.372 | 20.404 | 22.804 | 7.691 |
Total Equity | 82.61 | 147.266 | 115.135 | 156.905 | 124.098 |
Redeemable Preferred Stock | 0 | ||||
Common Stock | 0.071 | 0.07 | 0.038 | 0.033 | 0.025 |
Retained Earnings (Accumulated Deficit) | -357.019 | -290.872 | -230.311 | -171.138 | -119.765 |
Total Liabilities & Shareholders’ Equity | 110.865 | 174.736 | 143.84 | 188.574 | 140.34 |
Total Common Shares Outstanding | 66.7363 | 69.6988 | 38.1833 | 32.2668 | 25.4015 |
Additional Paid-In Capital | 442.237 | 438.113 | 345.394 | 327.9 | 243.903 |
Other Equity, Total | -0.161 | -0.045 | 0.014 | 0.11 | -0.065 |
Other Current Assets, Total | 0.175 | 0.311 | 0.247 | 0.648 | 0.388 |
Property/Plant/Equipment, Total - Gross | 34.819 | 33.603 | 34.552 | 35.915 | 17.828 |
Accumulated Depreciation, Total | -13.14 | -10.626 | -8.249 | -5.631 | -2.987 |
Long Term Investments | 0 | 8.041 | 7.502 | ||
Treasury Stock - Common | -2.518 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 62.359 | 79.782 | 97.458 | 111.097 | 124.418 |
Denarna sredstva in kratkoročne naložbe | 57.368 | 77.629 | 91.656 | 106.791 | 120.518 |
Denarna sredstva in ustrezniki | 25.539 | 15.861 | 15.622 | 30.901 | 20.851 |
Kratkoročne naložbe | 31.829 | 61.768 | 76.034 | 75.89 | 99.667 |
Prepaid Expenses | 4.991 | 2.153 | 4.302 | 4.306 | 3.9 |
Total Assets | 93.443 | 110.865 | 128.237 | 143.545 | 159.309 |
Property/Plant/Equipment, Total - Net | 20.432 | 21.679 | 22.141 | 23.498 | 23.975 |
Property/Plant/Equipment, Total - Gross | 34.101 | 34.819 | 34.668 | 35.382 | 35.202 |
Accumulated Depreciation, Total | -13.669 | -13.14 | -12.527 | -11.884 | -11.227 |
Other Long Term Assets, Total | 10.652 | 9.404 | 8.638 | 8.95 | 10.916 |
Total Current Liabilities | 9.737 | 12.122 | 11.602 | 8.906 | 9.664 |
Accounts Payable | 2.316 | 1.785 | 1.718 | 1.502 | 2.409 |
Accrued Expenses | 6.715 | 9.442 | 8.9 | 7.242 | 6.929 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.014 | 0.013 | 0.013 | 0.013 | 0.012 |
Total Liabilities | 24.731 | 28.255 | 27.809 | 26.195 | 27.015 |
Total Long Term Debt | 0.001 | 0.004 | 0.008 | 0.011 | 0.015 |
Other Liabilities, Total | 14.993 | 16.129 | 16.199 | 17.278 | 17.336 |
Total Equity | 68.712 | 82.61 | 100.428 | 117.35 | 132.294 |
Common Stock | 0.072 | 0.071 | 0.07 | 0.07 | 0.07 |
Additional Paid-In Capital | 443.829 | 442.237 | 441.072 | 440.124 | 439.138 |
Retained Earnings (Accumulated Deficit) | -372.641 | -357.019 | -340.323 | -322.411 | -306.569 |
Other Equity, Total | -0.03 | -0.161 | -0.391 | -0.433 | -0.345 |
Total Liabilities & Shareholders’ Equity | 93.443 | 110.865 | 128.237 | 143.545 | 159.309 |
Total Common Shares Outstanding | 68.0419 | 66.7363 | 70.2855 | 70.2302 | 70.2676 |
Celotne terjatve, neto | 1.5 | ||||
Accounts Receivable - Trade, Net | 1.5 | ||||
Other Current Liabilities, Total | 0.692 | 0.882 | 0.971 | 0.149 | 0.314 |
Capital Lease Obligations | 0.001 | 0.004 | 0.008 | 0.011 | 0.015 |
Long Term Investments | 0 | 0 | 0 | 0 | |
Treasury Stock - Common | -2.518 | -2.518 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -66.147 | -60.561 | -59.173 | -51.373 | -48.435 |
Denarna sredstva iz poslovanja | -56.888 | -52.198 | -39.553 | -75.468 | -42.47 |
Denarna sredstva iz poslovanja | 2.52 | 2.443 | 2.636 | 2.702 | 2.421 |
Nedenarne postavke | 6.016 | 5.72 | 5.622 | 4.222 | 2.924 |
Denarna sredstva Plačane obresti | 0.002 | 0.002 | 0.006 | 0.021 | 0.043 |
Spremembe v obratnem kapitalu | 0.723 | 0.2 | 11.362 | -31.019 | 0.62 |
Denarna sredstva pri naložbenju | 58.351 | -53.253 | 32.482 | 10.796 | -87.201 |
Kapitalski izdatki | -0.728 | -0.679 | -0.395 | -1.251 | -5.654 |
Celotne druge postavke denarnih tokov pri naložbenju | 59.079 | -52.574 | 32.877 | 12.047 | -81.547 |
Denarna sredstva pri financiranju | -2.04 | 89.382 | 13.394 | 79.604 | 82.483 |
Izdaja (odplačilo) delnic, neto | -2.027 | 89.463 | 13.602 | 79.87 | 82.91 |
Izdaja (odplačilo) dolga, neto | -0.013 | -0.008 | -0.208 | -0.266 | -0.427 |
Neto sprememba denarnih sredstev | -0.577 | -16.069 | 6.323 | 14.932 | -47.188 |
Postavke denarnega toka pri financiranju | 0 | -0.073 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.622 | -66.147 | -49.451 | -31.539 | -15.697 |
Cash From Operating Activities | -21.505 | -56.888 | -44.495 | -29.046 | -15.477 |
Cash From Operating Activities | 0.576 | 2.52 | 1.907 | 1.257 | 0.601 |
Non-Cash Items | 1.189 | 6.016 | 4.744 | 3.334 | 1.648 |
Cash Interest Paid | 0 | 0.002 | 0.002 | 0.001 | 0.001 |
Changes in Working Capital | -7.648 | 0.723 | -1.695 | -2.098 | -2.029 |
Cash From Investing Activities | 30.27 | 58.351 | 43.49 | 43.371 | 19.758 |
Capital Expenditures | -0.143 | -0.728 | -0.685 | -0.629 | -0.477 |
Other Investing Cash Flow Items, Total | 30.413 | 59.079 | 44.175 | 44 | 20.235 |
Cash From Financing Activities | 0.913 | -2.04 | 0.189 | 0.138 | 0.132 |
Financing Cash Flow Items | 0 | 0 | 0 | 0 | |
Issuance (Retirement) of Stock, Net | 0.915 | -2.027 | 0.198 | 0.144 | 0.135 |
Issuance (Retirement) of Debt, Net | -0.002 | -0.013 | -0.009 | -0.006 | -0.003 |
Net Change in Cash | 9.678 | -0.577 | -0.816 | 14.463 | 4.413 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Fidelity Management & Research Company LLC | Investment Advisor | 15.5077 | 10577970 | 0 | 2023-03-31 | LOW |
Ginkgo Bioworks Inc | Corporation | 9.2958 | 6340771 | 0 | 2023-04-01 | LOW |
OrbiMed Advisors, LLC | Investment Advisor/Hedge Fund | 8.8402 | 6029995 | 0 | 2023-04-01 | LOW |
Kryzanowski (John A) | Individual Investor | 6.5087 | 4439690 | 732534 | 2022-12-31 | |
New Enterprise Associates (NEA) | Venture Capital | 6.2005 | 4229410 | 470 | 2023-04-01 | LOW |
Atlas Venture | Venture Capital | 3.8879 | 2651963 | 0 | 2023-04-01 | LOW |
Alyeska Investment Group, L.P. | Hedge Fund | 3.6952 | 2520514 | -181549 | 2023-03-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.2892 | 2243586 | 0 | 2023-03-31 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 0.9962 | 679502 | 0 | 2023-03-31 | LOW |
UBS O'Connor LLC | Hedge Fund | 0.9314 | 635312 | 0 | 2023-03-31 | HIGH |
Sofinnova Investments, Inc | Venture Capital | 0.8429 | 574972 | 0 | 2023-03-31 | MED |
LMR Partners LLP | Hedge Fund | 0.755 | 515000 | 0 | 2023-03-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.6456 | 440381 | 14952 | 2023-03-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.6353 | 433323 | -37850 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.5864 | 400006 | 0 | 2023-03-31 | LOW |
Fiduciary Trust Company | Bank and Trust | 0.4916 | 335294 | 335294 | 2023-03-31 | LOW |
Ikarian Capital LLC | Hedge Fund | 0.4497 | 306757 | 0 | 2023-03-31 | HIGH |
Harbor Capital Advisors, Inc. | Investment Advisor | 0.3871 | 264026 | -47537 | 2023-03-31 | MED |
Two Sigma Investments, LP | Hedge Fund | 0.3679 | 250955 | 27303 | 2023-03-31 | HIGH |
Brennan (Aoife M) | Individual Investor | 0.3478 | 237259 | -29190 | 2023-04-03 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group530K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$46M+
Mesečni obseg naložb
$31M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Synlogic Company profile
O družbi Synlogic
Synlogic, Inc. je biofarmacevtsko podjetje v klinični fazi. Podjetje se osredotoča na odkrivanje in razvoj sintetičnih biotskih zdravil. Njen nabor izdelkov vključuje sintetična biotična zdravila za zdravljenje presnovnih motenj, vključno s fenilketonurijo (PKU) in enterično hiperoksalurijo. Glavni kandidat za izdelek družbe je SYNB1618, ki je peroralno zdravilo za zdravljenje PKU. Drugi kandidat za izdelek SYNB8802 se razvija za zdravljenje enterične hiperoksalurije. Družba je razvila zdravila Synthetic Biotic za zdravljenje nekaterih vrst raka, ki so namenjena spreminjanju tumorskega mikrookolja, aktiviranju imunskega sistema in posledično zmanjšanju tumorja. Podjetje razvija zdravilo SYNB1891 za zdravljenje solidnih tumorjev in limfoma. Družba izvaja klinično preskušanje faze II z zdravilom SYNB1618.
Industry: | Biotechnology & Medical Research (NEC) |
301 Binney St Ste 402
CAMBRIDGE
MASSACHUSETTS 02142-1030
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 530.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com